At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7,845 enrolled
Drug / intervention
Stent implantationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting
In Brief
An observational study evaluating Stent implantation for Coronary Artery Disease. Completed, enrolled 7,845 participants across 1 site.
Detailed Summary
The primary objective of the DELIVER Study is to assess the deliverability of the Resolute Integrity Stent as primary stent or as a secondary cross-over stent following delivery failure of another stent type in real world patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesNetherlands
CollaboratorsMedtronic Cardiac Rhythm and Heart Failure
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedFeb 2011
Primary CompletionOct 2012
Study CompletionApr 2013
TodayJul 2026
First PostedFeb 16, 2011
Enrollment StartFeb 1, 2011
Primary CompletionOct 1, 2012
Study CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 15.4 years ago
Interventions
Stent implantationdevice
Single arm, open label stent implantation